Skip to main content
Drug bottle and Pill

Compare Otezla vs. Cosentyx

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Otezla (apremilast) and Cosentyx (secukinumab) are both medications used to treat plaque psoriasis and psoriatic arthritis, but they belong to different medication classes. Otezla is a phosphodiesterase-4 (PDE-4) inhibitor taken by mouth twice daily, while Cosentyx is an interleukin 17 (IL-17) inhibitor injected under the skin once monthly. Otezla is also approved for treating mouth sores from Behçet’s disease, whereas Cosentyx is used for conditions like ankylosing spondylitis and hidradenitis suppurativa. Otezla requires a gradual increase in dosage to minimize side effects like nausea and diarrhea, while Cosentyx is typically started with a series of weekly injections followed by monthly maintenance doses. Generic versions of Otezla are FDA-approved but not yet available, whereas Cosentyx is a biologic medication and does not have a generic version. Common side effects of Otezla include diarrhea and nausea, while Cosentyx may increase the risk for infections, including the common cold. Additionally, because Cosentyx can increase the risk of infections it is not recommended with live vaccines.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.